SCHEMBL23938987

SCHEMBL23938987

BC1(N2C(=O)c3cccc(NC(O)(O)c4ccc(C(B)(B)N5CCOCC5)cc4F)c3C2(O)O)CCC(=O)NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19310114 0.94 — —
SCHEMBL21281531 0.85 — —
SCHEMBL21924031 0.84 — —
SCHEMBL21925699 0.79 — —
SCHEMBL19310075 0.77 — —
SCHEMBL23939101 0.77 — —
SCHEMBL21927112 0.77 — —
SCHEMBL23939088 0.77 — —
SCHEMBL19310286 0.76 — —
SCHEMBL21281330 0.74 CRBN (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-B1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF KANGPU BIOPHARMACEUTICALS LTD (CN) 2021-10-20 — — EP disclosed
Send feedback